Furthermore, accounting for the effects of age, ACA stiffening was evident from subjects with elevated levels of tau-based neuropathologies including neurofibrillary tangles, characteristic of both AD and CTE progression, though the effects of age were still prevalent. The gene discussed is MAPT; the disease is Alzheimer disease.